Neurology & Neurosurgery Research
POST COVID-19 POTS Study
Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult patients with Post–COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
AGE: 18+ years old
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: Yes
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: Yes
TYPE: Investigational Treatment Study
CONDITION: Postural Orthostatic Tachycardia Syndrome, POTS
CONDITION: Postural Orthostatic Tachycardia Syndrome, POTS
LOCATION: University Hospitals Cleveland Medical Center, UH Minoff Health Center
Learn More About This Research Study
For more information, please contact study coordinator, Mary Andrews, RRT, CCRP at 216-844-2386 and leave a message or complete the online form below.
Study Purpose
This study is examining the safety of an investigational drug in people with POST COVID-19 postural orthostatic tachycardia syndrome (POTS) and how well people tolerate it. It is also looking at how well the study drug works and is processed in people who have post-COVID-19 POST COVID-19 POTS.
Who Can Participate
Participants 18 years of age and older who have diagnosed with new-onset POTS post-COVID-19 may be eligible for this study.